This article first appeared in Digital Edge, The Edge Malaysia Weekly on April 8, 2024 - April 14, 2024

When the Inland Revenue Board (IRB) announced last year its intention to introduce mandatory e-invoicing for local companies

https://theedgemalaysia.com/node/707170

JAMES I NOT DREAMING ,

1.WE NOT TALK ABOUT GST BUT GAMING TAX. WE ARE CLEARLY UNDERSTAND THAT PM NOT GOING TO IMPLEMENT GST BUT WHAT IS OTHER SOURCE OF INCOME NEED BY GOVERTMENT. GAMING TAX. THIS IS HAPPEN IN 2018-2019 WHERE TO FILL THE NATION'S COFFERS, THE FINANCE MINISTRY (MOF) HAS RAISED CASINO DUTIES TO 35%, FROM 25%, ON GROSS GAMING INCOME AND GAMING MACHINE DUTIES TO 30%, FROM 20%, ON GROSS COLLECTION. ON TOP OF THAT, THE MOF HAS INCREASED THE ANNUAL CASINO LICENCE FEES BY RM30 MILLION TO RM150 MILLION, AND MACHINE DEALER'S LICENCE FEES TO RM50,000 A YEAR FROM RM10,000 A YEAR

2. REGARDING THE RESULT, AFTER COVID, THERE OTHER CASINO IN OTHER REGION SHOW THE BETTER RESULT BUT OUR CASE DIFFERENCE

NOW GENTING HAVE 2 HEAVY PRESSURE
1.NOT SO GOOD RESULT
2.THERE IS RUMOUR OF GOVERTMENT TAX

LAST TIME, I ALREADY LOST 60% AFTER GE-14. BETTER DONT

SHARE MARKET NOT EASY MONEY, LAST MINUTE SELL Q RM46,741,545

DIGI SELL Q DIE NOW 4.49PM

AirAsia expects to resume flying to most routes by the end of 2021, CEO Tony Fernandes says

https://www.cnbc.com/2021/01/26/airasia-ceo-tony-fernandes-on-aviation-industry-outlook.html

Vaccine month going to start

Thai AirAsia to furlough 75% of workforce

https://www.bangkokpost.com/business/2052947/thai-airasia-to-furlough-75-of-workforce

Somebody Waiting for V shape????. There is only L Shape to this counter

Govt considering opening borders to boost tourism - minister

https://m.malaysiakini.com/news/556738

Trap

KUALA LUMPUR (Dec 21): The second largest shareholder of Bintai Kinden Corp Bhd, whose share price has seen a roller-coaster ride this year, has sold its entire stake of 50.03 million shares or 14.4% interest in the engineering and construction group.

Nusankota Development Sdn Bhd disposed of its stake in the open market on Dec 16, according to a filing with Bursa Malaysia.

Nusankota Development acquired the stake for RM10.01 million back in March 2017, through a share swap by way of allotment of shares for the acquisition of the entire 100% equity interest in Optimal Property Management Sdn Bhd by Bintai Kinden.

Assuming that Nusankota Development sold the 50.03 million shares at the Dec 16 closing price of 86 sen per share, the total selling price of the stake would be RM43.02 million.

Interestingly, on the same day, Bintai Kinden's largest shareholder, Bintai Holdings (M) Sdn Bhd, also disposed of 28.5 million shares or a 8.14% stake in the group, reducing its shareholding in the group to 9.05% or 31.69 million shares.

The identities of the buyers in both transactions are not immediately known.

Bintai Kinden shares attracted fresh buying interest after the group announced in August a potential partnership with US-based Generex Biotechnology Corp and its subsidiary NuGenerex Immuno-Oncology Inc. The group went on to sign a distribution and licensing agreement with the US firms in October for their Covid-19 vaccine.

The agreement grants the group the exclusive right to distribute, sell and commercialise the vaccine in Southeast Asia. Bintai Kinden also has the right of first refusal to commercially exploit the vaccine in Australia and New Zealand as well as the global halal market.

Bintai Kinden' share price, which had been trading below 20 sen over the past three years, started jumping in August and reached a peak of RM1.37 on Dec 7 before giving up most of the gains. It was trading at 68 sen at the time of writing, giving a market capitalisation of RM239.81 million.

Still, year-to-date, Bintai Kinden's shares have risen 467% from 12 sen.

Trap

trap

This director must bring to court use pendamic factor, passport block. This company director must bring to court

Trap

Trap

Trap

Sinopharm,Cansino,Sinovac from China.Pfizer,Moderna,Johnson n Johnson,Novavax,Astrazeneca from US.Australia n New Zealand will not order from a penny stock US company that done 0 trial at the moment.Will not order at all those vaccines from China .Please read the international news.Dont follow the Shepherd as he walk with u.Take care......

Today, all time , i give signal trap......................

Frm yesterday i warning, trap + cut loss, but now too late.

Trap

Trap

Trap

Save your capital

Fake

Trap

Why this AAX comment silent now, make me afraid??????

GENTING SURE UP. GET READY. CLEAN CASE

The screening on all the workers conducted by the Ministry of Health Malaysia (MOH) came out negative. -Twitter / Resorts World Genting
://www.astroawani.com/berita-malaysia/covid-19-police-deny-genting-highlands-management-hiding-workers-tested-positive-273257?amp=1

Now genting in good trend. All money go to genting. Matter of time

Hahahaa. Right time to shine

Last time my enter price RM0.16. Luckily still hold & believe. Keep recover

Superbull

https://klse.i3investor.com/m/blog/superbullklse/2020-12-13-story-h1537564310-Genting_Berhad_recent_QR_and_outlook.jsp

Only one 1 group of people can earn Frm this counter. Director & cronies. Other all die

For this company local market still small, they try use Malaysia as hub, we can see clearly they agreement since beginning.

KUALA LUMPUR: The logistics cost of the ultra-cold Covid-19 vaccine will be borne by the pharmaceutical company Pfizer, says Khairy Jamaluddin (pic).

The Science, Technology and Innovation Minister said the deal signed with the pharmaceutical giant includes the shipment of the vaccine.


"There are deals, like with Pfizer where the cost we have paid (for the vaccine doses) consists of transportation costs, which is borne by Pfizer.

"The deals on (logistics cost) varies and it depends on the different companies.


"The final cost of it all is being looked at because it does not only involve transportation but also storage so we will scrutinise it when we get a clearer picture," he said in reply to Fahmi Fadzil (PH-Lembah Pantai) who had asked on the government's preparations to receive the vaccines and the additional costs involved for logistics on top of the RM3bil allocations announced.

Fahmi had also asked about the government's preparedness if there is a disruption in the supply chain for the vaccine, such as the one experienced by Pfizer currently.

Khairy said he is aware of media reports on the challenges in Pfizer's supply chain for raw materials used in its Covid-19 vaccines, which caused the company to slash its production target for 2020.

"But the same report also says it's only for this year. I was informed by Pfizer that this does not affect the supply for next year, which is for Malaysia.

"However, Malaysia, like other countries, have taken the portfolio vaccine approach to ensure we have enough supply.

"If we only depend on one company, then it may open us up to risks in securing enough vaccines," said Khairy.

In a Reuters report on Dec 4, a Pfizer spokeswoman said the company anticipates to produce 50 million doses of its Covid-19 vaccine this year.

This is down from an earlier target of 100 million doses.

Pfizer's vaccine requires two dose regions, which means the 50 million doses is only sufficient to inoculate 25 million people.

Khairy said Malaysia is targeting for 70% of its population to develop herd immunity under the national immunisation plan for Covid-19.

Thus far, Malaysia has signed two deals which have secured enough of the vaccine for 30% of the population.

Khairy said one is through the Optional Purchase Arrangement signed on Nov 23 which guarantees a vaccine supply for 10% of the population.

The second deal is with Pfizer, which was inked on Nov 24 to provide the vaccine supply for 20% of the population, or 12.8 million doses.

"For the remaining 40%, the government is still in discussion and negotiating with other pharmaceutical companies that are also developing the Covid-19 vaccines," said Khairy.

The Rembau MP said the government targets the first quarter of 2021 to receive its first batch of Covid-19 vaccine.

"However, the government will not compromise in terms of safety and efficacy of the vaccines procured.

"The final decision on the usage of a vaccine will only be done after a registration and approval decision is made by the National Pharmaceutical Regulatory Agency (NPRA) under the Health Ministry," said Khairy.

No need panic. See the full text of KJ

How China’s COVID-19 vaccines could fill the gaps left by Pfizer, Moderna, AstraZeneca

https://fortune.com/2020/12/05/china-covid-19-vaccines-approval-sinovac-sinopharm/

Get ready

Coronavirus: China to have 600 million doses of vaccines ‘ready for market this year’


https://www.scmp.com/news/china/society/article/3112570/coronavirus-china-have-600-million-doses-vaccines-ready-use-year

Last time I sold glove counter so early. This time i hold, next game is vaccine ...........

Half of today cases

COVID-19 | The Health Ministry reported 1,472 new Covid-19 cases as of noon today and three deaths.

Half of the new cases were from the Teratai cluster alone, which is linked to the Top Glove factory in Klang, Selangor.

Health director-general Dr Noor Hisham Abdullah said overall, the number of new infections in the country had reached a "more stable" rate.

This was because the majority of new transmissions were emerging from construction sites and factories.

Now more then 30% kenaaaa

30% of staff kena

Holding

Why limit up low

U working as what. Cleaner

Something wrong